Belal Amany, Elanany Mohamed A, Alsantali Reem I, Alrooqi Munira M, Mohamed Abdalla R, Hasabelnaby Sherifa
Department of Otorhinolaryngology, Head and Neck Surgery, The Second Affiliated Hospital of Xi'an Medical University, 710038 Xi'an, Shaanxi China.
Department of Pharmaceutical Chemistry, College of Pharmacy, Taif University, P.O. Box 11099 Taif, 21944 Saudi Arabia.
Russ J Bioorg Chem. 2022;48(2):438-456. doi: 10.1134/S1068162022330019. Epub 2022 May 26.
Rhinitis is an allergic disease that causes troubles and restlessness for patients. In this research work we will focus on finding promising organic molecules with potential ability to target histamine receptor with no sedative side effect. Phalazines and their isosteres, pyrimidines and pyridines have been reported to target H1 receptors, for this reason we have searched for library of these basic scaffolds, this library which has 184 organic molecules will be subjected for further explorations through computer aided drug design techniques. Swiss ADMET will be used to gather these compounds in clusters. Cluster with low potential to penetrate BBB is selected for virtual screening through pharmacophore model. Then molecular docking that revealed the stability of the complex formed between the investigated molecules and H1 receptor. ADMET profile showed three compounds (), (), and () with no toxicity on liver and no effect on CYP2D6, these three compounds were subjected to molecular dynamic simulations and compound () showed the most stable complex with the target protein (H1). Finally, we can say this work helped us to find new compounds with promising potential to target H1 without ability to penetrate BBB, so they can be used as useful candidates in treatment of rhinitis and deserve to be subjected for preclinical and clinical investigations.
The online version contains supplementary material available at 10.1134/S1068162022330019.
鼻炎是一种给患者带来困扰和不安的过敏性疾病。在这项研究工作中,我们将专注于寻找有潜力靶向组胺受体且无镇静副作用的有机分子。据报道,萘嗪及其电子等排体嘧啶和吡啶可靶向H1受体,因此我们搜索了这些基本骨架的库,这个包含184个有机分子的库将通过计算机辅助药物设计技术进行进一步探索。将使用瑞士ADMET将这些化合物聚类。选择穿透血脑屏障潜力低的聚类通过药效团模型进行虚拟筛选。然后进行分子对接,揭示所研究分子与H1受体之间形成的复合物的稳定性。ADMET分析显示三种化合物()、()和()对肝脏无毒性且对CYP2D6无影响,这三种化合物进行了分子动力学模拟,化合物()与靶蛋白(H1)形成的复合物最稳定。最后,我们可以说这项工作帮助我们找到了有潜力靶向H1但无穿透血脑屏障能力的新化合物,因此它们可作为治疗鼻炎的有用候选物,值得进行临床前和临床研究。
在线版本包含可在10.1134/S1068162022330019获取的补充材料。